Emcdonald on DSK2BSOYB1PROD with NOTICES

Federal Register / Vol. 76, No. 159 / Wednesday, August 17, 2011 / Notices 51035 

physical substances, or mixtures 

(collectively referred to as ‘‘substances’’) 

cause adverse health effects and 

provides opinions on whether these 

substances may be of concern given 

what is known about current human 

exposure levels. Assessments of 

potential adverse effects of 

environmental substances on 

reproduction or development carried 

out by CERHR from 1998–2010 are now 

conducted by OHAT. OHAT also 

organizes workshops or state-of-thescience evaluations to address issues of 

importance in environmental health 

sciences. OHAT assessments are 

published as NTP Monographs. 

Information about OHAT is found 

http://ntp.niehs.nih.gov/go/ohat. 

NTP panels are technical, scientific 

advisory bodies established on an ‘‘as 

needed’’ basis to provide independent 

scientific peer review and advise the 

NTP on agents of public health concern, 

new/revised toxicological test methods, 

or other issues. These panels help 

ensure transparent, unbiased, and 

scientifically rigorous input to the 

program for its use in making credible 

decisions about human hazard, setting 

research and testing priorities, and 

providing information to regulatory 

agencies about alternative methods for 

toxicity screening. The NTP welcomes 

nominations of scientific experts for 

upcoming panels. Scientists interested 

in serving on an NTP panel should 

provide a current curriculum vitae to 

Dr. Lori White (see ADDRESSES). The 

authority for NTP panels is provided by 

42 U.S.C. 217a; section 222 of the Public 

Health Service (PHS) Act, as amended. 

The panel is governed by the Federal 

Advisory Committee Act, as amended 

(5 U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

advisory committees. 

Dated: August 8, 2011. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2011–20958 Filed 8–16–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from Sandia National 

Laboratories in Albuquerque, New 

Mexico, as an addition to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. On 

July 29, 2011, the Secretary of HHS 

designated the following class of 

employees as an addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and its 

contractors and subcontractors who worked 

in any area at the Sandia National 

Laboratories in Albuquerque, New Mexico, 

from January 1, 1949 through December 31, 

1962, for a number of work days aggregating 

at least 250 work days, occurring either 

solely under this employment, or in 

combination with work days within the 

parameters established for one or more other 

classes of employees in the Special Exposure 

Cohort. 

This designation will become 

effective on September 9, 2011, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 877– 

222–7570. Information requests can also 

be submitted by e-mail to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2011–20925 Filed 8–16–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–11–08AJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to CDC Reports Clearance 

Officer, 1600 Clifton Road, MS–D74, 

Atlanta, GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communication Campaigns 

(OMB No. 0920–0800, exp. 1/31/2012)— 

Extension—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The mission of the CDC’s Division of 

Cancer Prevention and Control (DCPC) 

is to reduce the burden of cancer in the 

United States through cancer 

prevention, reduction of risk, early 

detection, better treatment, and 

improved quality of life for cancer 

survivors. Toward this end, the DCPC 

supports the scientific development, 

implementation, and evaluation of 

various health communication 

campaigns with an emphasis on specific 

cancer burdens. This process requires 

testing of messages, concepts, and 

materials prior to their final 

development and dissemination, as 

described in the second step of the 

health communication process, a 

scientific model developed by the U.S. 

Department of Health and Human 

Services’ National Cancer Institute to 

guide sound campaign development. 

CDC is currently approved to collect 

information for these purposes (OMB 

No. 0920–0800, exp. 1/31/2012). A 

three-year extension of the existing 

generic approval is requested. 

The communication literature 

supports various data collection 

methods to conduct credible formative,